# Andosan in Allergic and Asthma Patients

> **NCT05192720** · NA · COMPLETED · sponsor: **University Hospital, Akershus** · enrollment: 34 (actual)

## Conditions studied

- Allergic Asthma
- Allergic Rhinoconjunctivitis
- Immune Tolerance

## Interventions

- **DIETARY_SUPPLEMENT:** Andosan
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05192720
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-31
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-02-28
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05192720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05192720, "Andosan in Allergic and Asthma Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05192720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*